- Home
- AYTU vs APCX Comparison
AYTU vs APCX Comparison
Compare AYTU & APCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- APCX
- Stock Information
- Founded
- AYTU N/A
- APCX 2006
- Country
- AYTU United States
- APCX United States
- Employees
- AYTU N/A
- APCX N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- APCX Finance: Consumer Services
- Sector
- AYTU Health Care
- APCX Finance
- Exchange
- AYTU Nasdaq
- APCX Nasdaq
- Market Cap
- AYTU 9.8M
- APCX N/A
- IPO Year
- AYTU N/A
- APCX N/A
- Fundamental
- Price
- AYTU $1.38
- APCX $0.60
- Analyst Decision
- AYTU
- APCX
- Analyst Count
- AYTU 0
- APCX 0
- Target Price
- AYTU N/A
- APCX N/A
- AVG Volume (30 Days)
- AYTU 37.1K
- APCX 10.6M
- Earning Date
- AYTU 02-12-2025
- APCX 11-14-2024
- Dividend Yield
- AYTU N/A
- APCX N/A
- EPS Growth
- AYTU N/A
- APCX N/A
- EPS
- AYTU N/A
- APCX N/A
- Revenue
- AYTU $79,759,000.00
- APCX $365,000.00
- Revenue This Year
- AYTU N/A
- APCX $1,315.48
- Revenue Next Year
- AYTU N/A
- APCX N/A
- P/E Ratio
- AYTU N/A
- APCX N/A
- Revenue Growth
- AYTU N/A
- APCX N/A
- 52 Week Low
- AYTU $1.30
- APCX $0.31
- 52 Week High
- AYTU $3.45
- APCX $2.30
- Technical
- Relative Strength Index (RSI)
- AYTU 33.90
- APCX 60.21
- Support Level
- AYTU $1.30
- APCX $0.36
- Resistance Level
- AYTU $1.47
- APCX $1.49
- Average True Range (ATR)
- AYTU 0.12
- APCX 0.14
- MACD
- AYTU -0.01
- APCX 0.02
- Stochastic Oscillator
- AYTU 17.78
- APCX 24.32
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.